CDIO logo

Cardio Diagnostics Holdings (CDIO) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

14 January 2022

Indexes:

Not included

Description:

CDIO (Cardio Diagnostics Holdings) focuses on developing advanced diagnostic tools for cardiovascular health. The company aims to improve heart disease detection and management through innovative technologies, providing healthcare professionals with better insights to enhance patient care and outcomes.

Key Details

Price

$0.31

Annual Revenue

$17.10 K(+1800.00% YoY)

Annual EPS

-$0.66(+56.29% YoY)

Annual ROE

-230.77%

Beta

1.77

Events Calendar

Earnings

Next earnings date:

Nov 29, 2024

Recent quarterly earnings:

May 15, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

27 Aug '24 Benchmark
Speculative Buy
06 June '24 Benchmark
Speculative Buy
19 Apr '24 Benchmark
Speculative Buy
15 June '23 Benchmark
Speculative Buy
22 May '23 Northland Capital Markets
Outperform
18 Apr '23 Benchmark
Speculative Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum
Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum
Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum
CDIO
businesswire.com25 June 2024

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will sponsor a booth and showcase its groundbreaking cardiovascular solutions at the 2024 Onsite Employee Health Clinics Forum.

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality
Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality
Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality
CDIO
businesswire.com10 June 2024

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced the successful completion of its System and Organization Controls (SOC) 2 Type I audit.

Cardio Diagnostics shares rocket on validation of coronary heart disease detection test
Cardio Diagnostics shares rocket on validation of coronary heart disease detection test
Cardio Diagnostics shares rocket on validation of coronary heart disease detection test
CDIO
Proactive Investors20 November 2023

Cardio Diagnostics Holdings shares added more than 75% on Monday after positive results from a trial of the company's coronary heart disease (CHD) test PrecisionCHD were published in the Journal of the American Heart Association. The company noted that PrecisionCHD is a non-invasive and more accessible alternative to current CHD diagnosis tools being in the form of a blood test that uses AI and personalized genetic and epigenetic information to sensitively detect the presence of CHD.

Why Is Cardio Diagnostics (CDIO) Stock Up 45% Today?
Why Is Cardio Diagnostics (CDIO) Stock Up 45% Today?
Why Is Cardio Diagnostics (CDIO) Stock Up 45% Today?
CDIO
InvestorPlace31 October 2023

Shares of cardiovascular medicine specialist Cardio Diagnostics (NASDAQ: CDIO ) are skyrocketing on Tuesday following the announcement of a key deal. Specifically, Vizient has awarded Cardio Diagnostics an “Innovation Technology” contract for its artificial intelligence (AI) driven molecular heart disease tests.

FAQ

  • What is the primary business of Cardio Diagnostics Holdings?
  • What is the ticker symbol for Cardio Diagnostics Holdings?
  • Does Cardio Diagnostics Holdings pay dividends?
  • What sector is Cardio Diagnostics Holdings in?
  • What industry is Cardio Diagnostics Holdings in?
  • What country is Cardio Diagnostics Holdings based in?
  • When did Cardio Diagnostics Holdings go public?
  • Is Cardio Diagnostics Holdings in the S&P 500?
  • Is Cardio Diagnostics Holdings in the NASDAQ 100?
  • Is Cardio Diagnostics Holdings in the Dow Jones?
  • When was Cardio Diagnostics Holdings's last earnings report?
  • When does Cardio Diagnostics Holdings report earnings?
  • Should I buy Cardio Diagnostics Holdings stock now?

What is the primary business of Cardio Diagnostics Holdings?

CDIO (Cardio Diagnostics Holdings) focuses on developing advanced diagnostic tools for cardiovascular health. The company aims to improve heart disease detection and management through innovative technologies, providing healthcare professionals with better insights to enhance patient care and outcomes.

What is the ticker symbol for Cardio Diagnostics Holdings?

The ticker symbol for Cardio Diagnostics Holdings is NASDAQ:CDIO

Does Cardio Diagnostics Holdings pay dividends?

No, Cardio Diagnostics Holdings does not pay dividends

What sector is Cardio Diagnostics Holdings in?

Cardio Diagnostics Holdings is in the Healthcare sector

What industry is Cardio Diagnostics Holdings in?

Cardio Diagnostics Holdings is in the Biotechnology industry

What country is Cardio Diagnostics Holdings based in?

Cardio Diagnostics Holdings is headquartered in United States

When did Cardio Diagnostics Holdings go public?

Cardio Diagnostics Holdings's initial public offering (IPO) was on 14 January 2022

Is Cardio Diagnostics Holdings in the S&P 500?

No, Cardio Diagnostics Holdings is not included in the S&P 500 index

Is Cardio Diagnostics Holdings in the NASDAQ 100?

No, Cardio Diagnostics Holdings is not included in the NASDAQ 100 index

Is Cardio Diagnostics Holdings in the Dow Jones?

No, Cardio Diagnostics Holdings is not included in the Dow Jones index

When was Cardio Diagnostics Holdings's last earnings report?

Cardio Diagnostics Holdings's most recent earnings report was on 15 May 2024

When does Cardio Diagnostics Holdings report earnings?

The next expected earnings date for Cardio Diagnostics Holdings is 29 November 2024

Should I buy Cardio Diagnostics Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions